The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patients with Type II Diabetes: A Randomized Controlled Trial
Background: Given the high prevalence of type II diabetes and its complications, the evidence regarding the beneficial effects of probiotic yogurt on some cardiovascular biomarkers in diabetic patients is worthy of investigation. Aim: To investigate the effect of probiotic yogurt on blood glucose le...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Mashhad University of Medical Sciences
2017-01-01
|
Series: | Journal of Evidence-Based Care |
Subjects: | |
Online Access: | http://ebcj.mums.ac.ir/article_7984_a2c19ec3407440ff5a07b71844a5be6a.pdf |
id |
doaj-5fdd30f9bf36453b955b0c8b64b41aad |
---|---|
record_format |
Article |
spelling |
doaj-5fdd30f9bf36453b955b0c8b64b41aad2020-11-24T23:22:53ZfasMashhad University of Medical SciencesJournal of Evidence-Based Care2008-24872008-370X2017-01-0164263510.22038/ebcj.2016.79847984The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patients with Type II Diabetes: A Randomized Controlled TrialMahin Rezaei0Akram Sanagoo1Leila Jouybari2Naser Behnampoo3Ali Kavosi4MSc Student of Critical Care Nursing, School of Nursing & Midwifery, Golestan University of Medical Sciences, Gorgan, IranPhD of Nursing, Associate Professor, Nursing Research Center, Golestan University of Medical Sciences, Gorgan, IranPhD of Nursing, Associate Professor, Nursing Research Center, Golestan University of Medical Sciences, Gorgan, IranPhD of Biostatistics, Assistant Professor, School of Health, Golestan University of Medical Sciences, Gorgan, IranMsc of Nursing, Instructur, Department of Operating Room, Neyshabur University of Medical Sciences, Neyshabur, IranBackground: Given the high prevalence of type II diabetes and its complications, the evidence regarding the beneficial effects of probiotic yogurt on some cardiovascular biomarkers in diabetic patients is worthy of investigation. Aim: To investigate the effect of probiotic yogurt on blood glucose level and cardiovascular biomarkers in patients with type II diabetes. Method:This randomized, clinical trial was conducted on 90 patients with type II diabetes who visited the 5 Azar diabetes clinic in Gorgan, Iran, in 2014. The intervention group consumed three 100 g packages of probiotic yogurt per day for four weeks, while the control group used an equal amount of plain yogurt. Dietary intake, as well as anthropometric and biochemical parameters were measured before and after the trial. To analyze the data, independent t-test, paired t-test, and analysis of covariance were performed, using SPSS version 18. Results: The mean ages of the intervention and control groups were 50.49±10.92 and 50.13±9.20 years, respectively. In the intervention group, paired t-test showed significant differences between mean levels of blood glucose, cholesterol, low-density lipoprotein (LDL), triglycerides, diastolic blood pressure, and glycated hemoglobin before and after four weeks of daily intake of probiotic yogurt (P0.05). At the end of trial, the independent t-test showed a significant difference between the two groups in terms of mean levels of blood glucose, LDL, triglycerides, blood pressure, and glycated hemoglobin (Phttp://ebcj.mums.ac.ir/article_7984_a2c19ec3407440ff5a07b71844a5be6a.pdfBiomarkersBlood glucoseDiabetes mellitus type IIProbiotics |
collection |
DOAJ |
language |
fas |
format |
Article |
sources |
DOAJ |
author |
Mahin Rezaei Akram Sanagoo Leila Jouybari Naser Behnampoo Ali Kavosi |
spellingShingle |
Mahin Rezaei Akram Sanagoo Leila Jouybari Naser Behnampoo Ali Kavosi The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patients with Type II Diabetes: A Randomized Controlled Trial Journal of Evidence-Based Care Biomarkers Blood glucose Diabetes mellitus type II Probiotics |
author_facet |
Mahin Rezaei Akram Sanagoo Leila Jouybari Naser Behnampoo Ali Kavosi |
author_sort |
Mahin Rezaei |
title |
The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patients with Type II Diabetes: A Randomized Controlled Trial |
title_short |
The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patients with Type II Diabetes: A Randomized Controlled Trial |
title_full |
The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patients with Type II Diabetes: A Randomized Controlled Trial |
title_fullStr |
The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patients with Type II Diabetes: A Randomized Controlled Trial |
title_full_unstemmed |
The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patients with Type II Diabetes: A Randomized Controlled Trial |
title_sort |
effect of probiotic yogurt on blood glucose and cardiovascular biomarkers in patients with type ii diabetes: a randomized controlled trial |
publisher |
Mashhad University of Medical Sciences |
series |
Journal of Evidence-Based Care |
issn |
2008-2487 2008-370X |
publishDate |
2017-01-01 |
description |
Background: Given the high prevalence of type II diabetes and its complications, the evidence regarding the beneficial effects of probiotic yogurt on some cardiovascular biomarkers in diabetic patients is worthy of investigation. Aim: To investigate the effect of probiotic yogurt on blood glucose level and cardiovascular biomarkers in patients with type II diabetes. Method:This randomized, clinical trial was conducted on 90 patients with type II diabetes who visited the 5 Azar diabetes clinic in Gorgan, Iran, in 2014. The intervention group consumed three 100 g packages of probiotic yogurt per day for four weeks, while the control group used an equal amount of plain yogurt. Dietary intake, as well as anthropometric and biochemical parameters were measured before and after the trial. To analyze the data, independent t-test, paired t-test, and analysis of covariance were performed, using SPSS version 18. Results: The mean ages of the intervention and control groups were 50.49±10.92 and 50.13±9.20 years, respectively. In the intervention group, paired t-test showed significant differences between mean levels of blood glucose, cholesterol, low-density lipoprotein (LDL), triglycerides, diastolic blood pressure, and glycated hemoglobin before and after four weeks of daily intake of probiotic yogurt (P0.05). At the end of trial, the independent t-test showed a significant difference between the two groups in terms of mean levels of blood glucose, LDL, triglycerides, blood pressure, and glycated hemoglobin (P |
topic |
Biomarkers Blood glucose Diabetes mellitus type II Probiotics |
url |
http://ebcj.mums.ac.ir/article_7984_a2c19ec3407440ff5a07b71844a5be6a.pdf |
work_keys_str_mv |
AT mahinrezaei theeffectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial AT akramsanagoo theeffectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial AT leilajouybari theeffectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial AT naserbehnampoo theeffectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial AT alikavosi theeffectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial AT mahinrezaei effectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial AT akramsanagoo effectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial AT leilajouybari effectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial AT naserbehnampoo effectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial AT alikavosi effectofprobioticyogurtonbloodglucoseandcardiovascularbiomarkersinpatientswithtypeiidiabetesarandomizedcontrolledtrial |
_version_ |
1725566395506229248 |